Overall, it appears that understanding the diverse abilities of IGFBP3 is certainly not straightforward, and more mechanistic studies, possibly on breast cancer stem cells, are needed to establish whether IGFBP3 could be exploited in breast cancer therapy. This evidence concerns the gene IGFBP3 and breast cancer.